Technical Analysis for FLXN - Flexion Therapeutics, Inc.

Grade Last Price % Change Price Change
D 7.98 5.98% 0.45
FLXN closed up 5.98 percent on Thursday, May 13, 2021, on approximately normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up
Historical FLXN trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
Earnings Movers Other 0.00%
Wide Bands Range Expansion 0.00%
Up 3 Days in a Row Strength 0.00%
Slingshot Bearish Bearish Swing Setup 5.98%
Earnings Movers Other 5.98%
Wide Bands Range Expansion 5.98%
Older End-of-Day Signals for FLXN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
20 DMA Resistance about 15 hours ago
Rose Above 20 DMA about 15 hours ago
Up 5% about 15 hours ago
Up 1 ATR about 15 hours ago
60 Minute Opening Range Breakout about 16 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Flexion Therapeutics, Inc. focuses on the development and commercialization of anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. Its lead product candidate includes FX006, an intra-articular, sustained-release triamcinolone acetonide, which has completed a Phase 2b dose-ranging clinical trial to treat moderate to severe osteoarthritis (OA) pain. The company is also developing FX007, a preclinical, small-molecule TrkA receptor antagonist to address post-operative pain; and FX005, an intra-articular, sustained-release p38 MAP kinase inhibitor, which has completed a Phase 2a clinical trial to treat end-stage OA patients. Flexion Therapeutics, Inc. was founded in 2007 and is headquartered in Burlington, Massachusetts.
Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Pain Organic Compounds Osteoarthritis Organic Chemistry Arthritis Glucocorticoids Skeletal Disorders Organofluorides

Is FLXN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 14.39
52 Week Low 6.73
Average Volume 1,093,342
200-Day Moving Average 11.16
50-Day Moving Average 9.15
20-Day Moving Average 8.02
10-Day Moving Average 7.49
Average True Range 0.54
ADX 33.01
+DI 19.07
-DI 26.87
Chandelier Exit (Long, 3 ATRs ) 8.14
Chandelier Exit (Short, 3 ATRs ) 8.34
Upper Bollinger Band 9.27
Lower Bollinger Band 6.78
Percent B (%b) 0.48
BandWidth 31.05
MACD Line -0.48
MACD Signal Line -0.53
MACD Histogram 0.0434
Fundamentals Value
Market Cap 393.53 Million
Num Shares 49.3 Million
EPS -4.28
Price-to-Earnings (P/E) Ratio -1.87
Price-to-Sales 5.77
Price-to-Book 35.62
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.23
Resistance 3 (R3) 9.13 8.62 9.02
Resistance 2 (R2) 8.62 8.30 8.67 8.95
Resistance 1 (R1) 8.30 8.11 8.46 8.40 8.88
Pivot Point 7.79 7.79 7.87 7.84 7.79
Support 1 (S1) 7.47 7.47 7.63 7.57 7.08
Support 2 (S2) 6.96 7.28 7.01 7.01
Support 3 (S3) 6.64 6.96 6.94
Support 4 (S4) 6.74